Finance

Lists
ADXN:NASDAQ
Addex Therapeutics Ltd - ADR
3,14ย US$
+1,29%
(+0,040) 1D
6 แƒแƒฅแƒข, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADXN...
Open
3,15ย US$
High
3,20ย US$
Low
3,14ย US$
Mkt. cap
5,93ย แƒ›แƒšแƒœ.
Avg. vol.
42,62ย แƒแƒ—.
Volume
1,75ย แƒแƒ—.
52-wk high
11,97ย US$
52-wk low
2,56ย US$
EPS
-8,42ย US$
Beta
1,52
Shares outstanding
1,82ย แƒ›แƒšแƒœ.
No. of employees
3
Open
3,15ย US$
High
3,20ย US$
Low
3,14ย US$
Mkt. cap
5,93ย แƒ›แƒšแƒœ.
Avg. vol.
42,62ย แƒแƒ—.
Volume
1,75ย แƒแƒ—.
52-wk high
11,97ย US$
52-wk low
2,56ย US$
EPS
-8,42ย US$
Beta
1,52
Shares outstanding
1,82ย แƒ›แƒšแƒœ.
No. of employees
3
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
17 แƒฌแƒฃแƒ—แƒ˜แƒก แƒฌแƒ˜แƒœ
How $950 Million Settlement Will Impact Roivant Sciences Stock (ROIV)
Moomoo
Moomoo
·
58 แƒฌแƒฃแƒ—แƒ˜แƒก แƒฌแƒ˜แƒœ
๐Ÿ† S&P 500 tops 7,800 for first time as tech rally defies surging yields
CNBC
CNBC
·
5 แƒกแƒแƒแƒ—แƒ˜แƒก แƒฌแƒ˜แƒœ
Chart: A look at the S&P 500's remarkable and defiant trip to a new record
About Addex Therapeutics Ltd - ADR
CEO-
Employees3
Founded2002
Headquarters-
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
แƒกแƒ”แƒฅ. 2025
แƒ“แƒ”แƒ™. 2025
แƒ›แƒแƒ . 2026
แƒ˜แƒ•แƒœ. 2026
Revenue
49,60ย แƒแƒ—.
15,83ย แƒแƒ—.
7,69ย แƒแƒ—.
9,95ย แƒแƒ—.
Cost of goods sold
228,32ย แƒแƒ—.
52,81ย แƒแƒ—.
36,13ย แƒแƒ—.
37,99ย แƒแƒ—.
Cost of revenue
228,32ย แƒแƒ—.
52,81ย แƒแƒ—.
36,13ย แƒแƒ—.
37,99ย แƒแƒ—.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
517,45ย แƒแƒ—.
742,28ย แƒแƒ—.
451,39ย แƒแƒ—.
617,31ย แƒแƒ—.
Operating expense
517,45ย แƒแƒ—.
742,28ย แƒแƒ—.
451,39ย แƒแƒ—.
617,31ย แƒแƒ—.
Total operating expenses
745,78ย แƒแƒ—.
795,09ย แƒแƒ—.
487,52ย แƒแƒ—.
655,30ย แƒแƒ—.
Operating income
-696,18ย แƒแƒ—.
-779,26ย แƒแƒ—.
-479,83ย แƒแƒ—.
-645,35ย แƒแƒ—.
Other non operating income
-
-
-
3,38ย แƒแƒ—.
EBT including unusual items
-1,58ย แƒ›แƒšแƒœ.
-1,83ย แƒ›แƒšแƒœ.
-1,71ย แƒ›แƒšแƒœ.
-1,74ย แƒ›แƒšแƒœ.
EBT excluding unusual items
-1,58ย แƒ›แƒšแƒœ.
-1,83ย แƒ›แƒšแƒœ.
-1,71ย แƒ›แƒšแƒœ.
-1,74ย แƒ›แƒšแƒœ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,58ย แƒ›แƒšแƒœ.
-1,84ย แƒ›แƒšแƒœ.
-1,71ย แƒ›แƒšแƒœ.
-1,74ย แƒ›แƒšแƒœ.
Net profit margin
-3ย 179,90%
-11ย 604,47%
-22ย 256,39%
-17ย 537,99%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-472,00
-575,00
-956,00
-1,18ย แƒแƒ—.
Net interest expenses
-472,00
-575,00
-956,00
-1,18ย แƒแƒ—.
Depreciation and amortization charges
-
-
-
-
EBITDA
-696,07ย แƒแƒ—.
-779,16ย แƒแƒ—.
-479,72ย แƒแƒ—.
-645,25ย แƒแƒ—.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google แƒแƒžแƒ”แƒ‘แƒ˜